 | Up a level |
May, Margaret; Sterne, Jonathan A C; Shipley, Martin; Brunner, Eric; d'Agostino, Ralph; Whincup, Peter; Ben-Shlomo, Yoav; Carr, Andrew; Ledergerber, Bruno; Lundgren, Jens D; Phillips, Andrew N; Massaro, Joseph; Egger, Matthias (2007). A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men. International journal of epidemiology, 36(6), pp. 1309-18. Oxford: Oxford University Press 10.1093/ije/dym135
May, M; Sterne, JA; Sabin, C; Costagliola, D; Justice, AC; Thiébaut, R; Gill, J; Phillips, A; Reiss, P; Hogg, R; Ledergerber, B; D'Arminio Monforte, A; Schmeisser, N; Staszewski, S; Antiretroviral, Therapy (ART) Cohort Collaboration (2007). Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS, 21(9), pp. 1185-1197. Hagerstown, Md.: Lippincott Williams & Wilkins
Low, N; McCarthy, A; Macleod, J; Salisbury, C; Campbell, R; Roberts, TE; Horner, P; Skidmore, S; Sterne, JA; Sanford, E; Ibrahim, F; Holloway, A; Patel, R; Barton, PM; Robinson, SM; Mills, N; Graham, A; Herring, A; Caul, EO; Davey Smith, G; ... (2007). Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health technology assessment, 11(8), iii-iv, ix-xii, 1-165. Southampton, UK: National Coordinating Centre for Health Technology Assessment
Sterne, JA; May, M; Bucher, HC; Ledergerber, B; Furrer, H; Cavassini, M; Bernasconi, E; Hirschel, B; Egger, M; Swiss, HIV Cohort (2007). HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy. Journal of internal medicine, 261(3), pp. 255-67. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2796.2006.01761.x
The, Antiretroviral Therapy (ART) Cohort Collaboration; Sterne, JA; May, M; Sabin, C; Phillips, A; Costagniola, D; Chêne, G; Justice, AC; De Wolf, F; Hogg, R; Battegay, M; D'Arminio Monforte, A; Fätkenheuer, G; Staszewski, S; Gill, J; Egger, M (2007). Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy. Journal of acquired immune deficiency syndromes JAIDS, 46(5), pp. 607-615. Philadelphia, Pa.: Lippincott Williams & Wilkins
Whiting, Penny; Toerien, Merran; de Salis, Isabel; Sterne, Jonathan A C; Dieppe, Paul; Egger, Matthias; Fahey, Tom (2007). A review identifies and classifies reasons for ordering diagnostic tests. Journal of clinical epidemiology, 60(10), pp. 981-9. New York, N.Y.: Elsevier 10.1016/j.jclinepi.2007.01.012
Braitstein, P; Brinkhof, MW; Dabis, F; Schechter, M; Boulle, A; Miotti, P; Wood, R; Laurent, C; Sprinz, E; Seyler, C; Bangsberg, DR; Balestre, E; Sterne, JA; May, M; Egger, M; Antiretroviral, Therapy in Lower Income Countries (ART-LINC) Collaboration; Cohort Collaboration (ART-CC) groups, ART (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet, 367(9513), pp. 817-824. London: Elsevier 10.1016/S0140-6736(06)69886-3
Skidmore, S; Horner, P; Herring, A; Sell, J; Paul, I; Thomas, J; Caul, EO; Egger, M; McCarthy, A; Sanford, E; Salisbury, C; Macleod, J; Sterne, JA; Low, N; Chlamydia, Screening Studies (ClaSS) Project Group (2006). Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting? Journal of clinical microbiology, 44(12), 4389-94. Epub 2006 Oct 25.. Washington, D.C.: American Society for Microbiology 10.1128/JCM.01060-06
Harbord, Roger M; Egger, Matthias; Sterne, Jonathan A C (2006). A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in medicine, 25(20), 3443-57.. Hoboken, N.J.: Wiley-Blackwell 10.1002/sim.2380
May, MT; Sterne, JA; Costagliola, D; Sabin, CA; Phillips, AN; Justice, AC; Dabis, F; Gill, J; Lundgren, J; Hogg, RS; de Wolf, F; Fätkenheuer, G; Staszewski, S; d'Arminio Monforte, A; Egger, Matthias; The Antiretroviral Therapy (ART) Cohort Collaboration, (2006). HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet, 368(9534), pp. 451-458. London: Elsevier 10.1016/S0140-6736(06)69152-6
Low, N; Egger, M; Sterne, J A C; Harbord, R M; Ibrahim, F; Lindblom, B; Herrmann, B (2006). Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sexually transmitted infections, 82(3), 212-8.. London: BMJ Publishing Group 10.1136/sti.2005.17186
Whiting, Penny; Harbord, Roger; Main, Caroline; Deeks, Jonathan J; Filippini, Graziella; Egger, Matthias; Sterne, Jonathan A C (2006). Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review. BMJ, 332(7546), pp. 875-884. London: BMJ Publishing Group 10.1136/bmj.38771.583796.7C
Salisbury, Chris; Macleod, John; Egger, Matthias; McCarthy, Anne; Patel, Rita; Holloway, Aisha; Ibrahim, Fowzia; Sterne, Jonathan A C; Horner, Paddy; Low, Nicola (2006). Opportunistic and systematic screening for chlamydia: a study of consultations by young adults in general practice. British journal of general practice, 56(523), 99-103.. London: Royal College of General Practitioners
Low, Nicola; McCarthy, Anne; Roberts, Tracy E; Huengsberg, Mia; Sanford, Emma; Sterne, Jonathan A C; Macleod, John; Salisbury, Chris; Pye, Karl; Holloway, Aisha; Morcom, Andrea; Patel, Rita; Robinson, Suzanne M; Horner, Paddy; Barton, Pelham M; Egger, Matthias (2006). Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use. BMJ, 332(7532), p. 14. London: BMJ Publishing Group 10.1136/bmj.38678.405370.7C
